Skyhawk Therapeutics: expansión de su ensayo clínico FALCON-HD para SKY-0515 en la enfermedad de Huntington

Trial StartSKY-0515Positive

AI Analysis

Summary

Skyhawk Therapeutics announces expansion of its FALCON-HD clinical trial for SKY-0515 in Huntington's disease across the United States, Canada, and United Kingdom, with more than ten countries and over twenty sites now participating in the global pivotal study.

Clinical Trial Data

Importance:5/10

Sentiment:

0.50

clinical trial expansionHuntington's diseaseSKY-0515FALCON-HD

Related Companies

$GBCYD

Read the original article

Published by PR Newswire Biotech on July 14, 2026 2:34 PM

Read Original